Arkolith/Insider Trading/CLSD/Form 4

Ciulla Thomas

Chief Medical OfficerClearside Biomedical, Inc. (CLSD) · full profile →Form 4 · filed Jan 6, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 31, 2022Grant(A)5K$0.95$5K308K
Jun 30, 2022Grant(A)5K$1.25$6K303K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 4, 2023Grant(A)188K—$0188K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-002341) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML